Cargando…

The Effect of Sodium-Dependent Glucose Cotransporter 2 Inhibitor Tofogliflozin on Neurovascular Coupling in the Retina in Type 2 Diabetic Mice

We investigated the effect of tofogliflozin, a sodium-dependent glucose cotransporter 2 inhibitor (SGLT2i), on retinal blood flow dysregulation, neural retinal dysfunction, and the impaired neurovascular coupling in type 2 diabetic mice. Tofogliflozin was added to mouse chow to deliver 5 mg/kg/day a...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanaguri, Junya, Yokota, Harumasa, Kushiyama, Akifumi, Kushiyama, Sakura, Watanabe, Masahisa, Yamagami, Satoru, Nagaoka, Taiji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835894/
https://www.ncbi.nlm.nih.gov/pubmed/35163285
http://dx.doi.org/10.3390/ijms23031362
_version_ 1784649544566308864
author Hanaguri, Junya
Yokota, Harumasa
Kushiyama, Akifumi
Kushiyama, Sakura
Watanabe, Masahisa
Yamagami, Satoru
Nagaoka, Taiji
author_facet Hanaguri, Junya
Yokota, Harumasa
Kushiyama, Akifumi
Kushiyama, Sakura
Watanabe, Masahisa
Yamagami, Satoru
Nagaoka, Taiji
author_sort Hanaguri, Junya
collection PubMed
description We investigated the effect of tofogliflozin, a sodium-dependent glucose cotransporter 2 inhibitor (SGLT2i), on retinal blood flow dysregulation, neural retinal dysfunction, and the impaired neurovascular coupling in type 2 diabetic mice. Tofogliflozin was added to mouse chow to deliver 5 mg/kg/day and 6-week-old mice were fed for 8 weeks. The longitudinal changes in the retinal neuronal function and blood flow responses to systemic hyperoxia and flicker stimulation were evaluated every 2 weeks in diabetic db/db mice that received tofogliflozin (n =6) or placebo (n = 6) from 8 to 14 weeks of age. We also evaluated glial activation and vascular endothelial growth factor (VEGF) expression by immunofluorescence. Tofogliflozin treatment caused a sustained decrease in blood glucose in db/db mice from 8 weeks of the treatment. In tofogliflozin-treated db/db mice, both responses improved from 8 to 14 weeks of age, compared with vehicle-treated diabetic mice. Subsequently, the electroretinography implicit time for the oscillatory potential was significantly improved in SGLT2i-treated db/db mice. The systemic tofogliflozin treatment prevented the activation of glial fibrillary acidic protein and VEGF protein expression, as detected by immunofluorescence. Our results suggest that glycemic control with tofogliflozin significantly improved the impaired retinal neurovascular coupling in type 2 diabetic mice with the inhibition of retinal glial activation.
format Online
Article
Text
id pubmed-8835894
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88358942022-02-12 The Effect of Sodium-Dependent Glucose Cotransporter 2 Inhibitor Tofogliflozin on Neurovascular Coupling in the Retina in Type 2 Diabetic Mice Hanaguri, Junya Yokota, Harumasa Kushiyama, Akifumi Kushiyama, Sakura Watanabe, Masahisa Yamagami, Satoru Nagaoka, Taiji Int J Mol Sci Article We investigated the effect of tofogliflozin, a sodium-dependent glucose cotransporter 2 inhibitor (SGLT2i), on retinal blood flow dysregulation, neural retinal dysfunction, and the impaired neurovascular coupling in type 2 diabetic mice. Tofogliflozin was added to mouse chow to deliver 5 mg/kg/day and 6-week-old mice were fed for 8 weeks. The longitudinal changes in the retinal neuronal function and blood flow responses to systemic hyperoxia and flicker stimulation were evaluated every 2 weeks in diabetic db/db mice that received tofogliflozin (n =6) or placebo (n = 6) from 8 to 14 weeks of age. We also evaluated glial activation and vascular endothelial growth factor (VEGF) expression by immunofluorescence. Tofogliflozin treatment caused a sustained decrease in blood glucose in db/db mice from 8 weeks of the treatment. In tofogliflozin-treated db/db mice, both responses improved from 8 to 14 weeks of age, compared with vehicle-treated diabetic mice. Subsequently, the electroretinography implicit time for the oscillatory potential was significantly improved in SGLT2i-treated db/db mice. The systemic tofogliflozin treatment prevented the activation of glial fibrillary acidic protein and VEGF protein expression, as detected by immunofluorescence. Our results suggest that glycemic control with tofogliflozin significantly improved the impaired retinal neurovascular coupling in type 2 diabetic mice with the inhibition of retinal glial activation. MDPI 2022-01-25 /pmc/articles/PMC8835894/ /pubmed/35163285 http://dx.doi.org/10.3390/ijms23031362 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Hanaguri, Junya
Yokota, Harumasa
Kushiyama, Akifumi
Kushiyama, Sakura
Watanabe, Masahisa
Yamagami, Satoru
Nagaoka, Taiji
The Effect of Sodium-Dependent Glucose Cotransporter 2 Inhibitor Tofogliflozin on Neurovascular Coupling in the Retina in Type 2 Diabetic Mice
title The Effect of Sodium-Dependent Glucose Cotransporter 2 Inhibitor Tofogliflozin on Neurovascular Coupling in the Retina in Type 2 Diabetic Mice
title_full The Effect of Sodium-Dependent Glucose Cotransporter 2 Inhibitor Tofogliflozin on Neurovascular Coupling in the Retina in Type 2 Diabetic Mice
title_fullStr The Effect of Sodium-Dependent Glucose Cotransporter 2 Inhibitor Tofogliflozin on Neurovascular Coupling in the Retina in Type 2 Diabetic Mice
title_full_unstemmed The Effect of Sodium-Dependent Glucose Cotransporter 2 Inhibitor Tofogliflozin on Neurovascular Coupling in the Retina in Type 2 Diabetic Mice
title_short The Effect of Sodium-Dependent Glucose Cotransporter 2 Inhibitor Tofogliflozin on Neurovascular Coupling in the Retina in Type 2 Diabetic Mice
title_sort effect of sodium-dependent glucose cotransporter 2 inhibitor tofogliflozin on neurovascular coupling in the retina in type 2 diabetic mice
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835894/
https://www.ncbi.nlm.nih.gov/pubmed/35163285
http://dx.doi.org/10.3390/ijms23031362
work_keys_str_mv AT hanagurijunya theeffectofsodiumdependentglucosecotransporter2inhibitortofogliflozinonneurovascularcouplingintheretinaintype2diabeticmice
AT yokotaharumasa theeffectofsodiumdependentglucosecotransporter2inhibitortofogliflozinonneurovascularcouplingintheretinaintype2diabeticmice
AT kushiyamaakifumi theeffectofsodiumdependentglucosecotransporter2inhibitortofogliflozinonneurovascularcouplingintheretinaintype2diabeticmice
AT kushiyamasakura theeffectofsodiumdependentglucosecotransporter2inhibitortofogliflozinonneurovascularcouplingintheretinaintype2diabeticmice
AT watanabemasahisa theeffectofsodiumdependentglucosecotransporter2inhibitortofogliflozinonneurovascularcouplingintheretinaintype2diabeticmice
AT yamagamisatoru theeffectofsodiumdependentglucosecotransporter2inhibitortofogliflozinonneurovascularcouplingintheretinaintype2diabeticmice
AT nagaokataiji theeffectofsodiumdependentglucosecotransporter2inhibitortofogliflozinonneurovascularcouplingintheretinaintype2diabeticmice
AT hanagurijunya effectofsodiumdependentglucosecotransporter2inhibitortofogliflozinonneurovascularcouplingintheretinaintype2diabeticmice
AT yokotaharumasa effectofsodiumdependentglucosecotransporter2inhibitortofogliflozinonneurovascularcouplingintheretinaintype2diabeticmice
AT kushiyamaakifumi effectofsodiumdependentglucosecotransporter2inhibitortofogliflozinonneurovascularcouplingintheretinaintype2diabeticmice
AT kushiyamasakura effectofsodiumdependentglucosecotransporter2inhibitortofogliflozinonneurovascularcouplingintheretinaintype2diabeticmice
AT watanabemasahisa effectofsodiumdependentglucosecotransporter2inhibitortofogliflozinonneurovascularcouplingintheretinaintype2diabeticmice
AT yamagamisatoru effectofsodiumdependentglucosecotransporter2inhibitortofogliflozinonneurovascularcouplingintheretinaintype2diabeticmice
AT nagaokataiji effectofsodiumdependentglucosecotransporter2inhibitortofogliflozinonneurovascularcouplingintheretinaintype2diabeticmice